Cargando…
Impact of recombinant human brain natriuretic peptide on emergency dialysis and prognosis in end-stage renal disease patients with type 4 cardiorenal syndrome
Recombinant human brain natriuretic peptide (rhBNP) effects on type 4 cardiorenal syndrome (CRS) and adverse events such as heart failure rehospitalization and all-cause mortality have not been assessed in large-scale research. This study evaluated the impact of rhBNP on emergency dialysis and progn...
Autores principales: | Zhou, Yue, Wang, Xiaojian, Yuan, Hongbo, Wu, Linke, Zhang, Bin, Chen, Xiaoxia, Zhang, Yafeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676370/ https://www.ncbi.nlm.nih.gov/pubmed/38007545 http://dx.doi.org/10.1038/s41598-023-48125-1 |
Ejemplares similares
-
Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence
por: Koratala, Abhilash, et al.
Publicado: (2017) -
B-Type Natriuretic Peptide and Prognosis of End-Stage Renal Disease: A Meta-Analysis
por: Cheng, Yun-Jiu, et al.
Publicado: (2013) -
N-terminal prohormone B-type natriuretic peptide variability acts as a predictor of poor prognosis in patients with cardiorenal syndrome type 2
por: Ma, Mingming, et al.
Publicado: (2021) -
Total Bilirubin in Prognosis for Mortality in End‐Stage Renal Disease Patients on Peritoneal Dialysis Therapy
por: Yang, Tsung‐Lin, et al.
Publicado: (2017) -
Chronic inflammation in end-stage renal disease and dialysis
por: Cobo, Gabriela, et al.
Publicado: (2018)